Immuno-oncology clinical trials take a turn beyond PD1/PDL1 inhibitors
Ana Rosa Saez-Ibañez, Samik Upadhaya, Jay R. Campbell
Topics & Concepts
MedicineClinical trialOncologyClinical OncologyInternal medicineIntensive care medicineCancerTuberculosis Research and EpidemiologySynthesis and Biological EvaluationChronic Lymphocytic Leukemia Research